HOME >> BIOLOGY >> NEWS
Experimental smallpox vaccine protects against monkeypox in nonhuman primates

Scientists evaluating MVA, a potential safer replacement for the licensed Dryvax smallpox vaccine, have shown that MVA elicits an immune response comparable to that of Dryvax in a monkeypox model of human disease. In addition, MVA protected nonhuman primates exposed to lethal doses of the monkeypox virus.

The study, published in the March 11th issue of the journal NATURE, is a collaborative effort involving a team of scientists from the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), the National Institute of Allergy and Infectious Diseases (NIAID), the Henry M. Jackson Foundation, and the University of Pennsylvania.

Their findings represent an important step in the search for an alternative vaccine to Dryvax, which contains a live virus called Vaccinia that carries a high risk of adverse complications for people with suppressed immune systems.

Smallpox, a devastating disease caused by the Variola virus, was eradicated in 1979 through the efforts of the World Health Organization (WHO). Currently, infectious Variola (a species of the genus Orthopoxvirus) is known to exist only in two WHO-sanctioned repositories, one in Russia and the other at the Centers for Disease Control and Prevention in Atlanta. However, there is concern that undisclosed reference stocks of the virus may exist, and its potential as a biological weapon has led to the production and stockpiling of smallpox vaccine and the immunization of some healthcare workers.

Because Variola no longer occurs naturally, vaccines cannot be tested for their ability to prevent smallpox in humans. Thus, licensing of future vaccine candidates will include studies of immune response and protection in nonhuman primates. According to the authors, monkeypox currently provides the best nonhuman primate model of an Orthopoxvirus infection.

MVA is made from the same Vaccinia virus present in the Dryvax product. The difference is that MVA is extremely at
'"/>

Contact: Caree Vander Linden
Caree.Vander-Linden@amedd.army.mil
301-619-2285
US Army Medical Research Institute of Infectious Diseases
10-Mar-2004


Page: 1 2

Related biology news :

1. Experimental drug shown to block mutant protein causing blood disease
2. Experimental smallpox DNA vaccine protects primates from lethal monkeypox
3. Experimental Biology 2004 - Translating the Genome
4. Experimental Biology 2004 meets in Washington, D.C. April 17-21
5. Experimental hantavirus vaccine elicits strong antibody response in primates
6. Experimental cancer drugs may halt events that lead to cardiac hypertrophy and heart failure
7. Experimental Biology 2003 meets in San Diego April 11-15
8. Experimental Biology 2003 meets in San Diego April 11-15
9. Experimental gene switch increases lifespan with no ill effects
10. Experimental therapy stops allergic reactions in mice
11. APS awards 44 minority travel fellowships to the Experimental Biology 2002 meeting

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/26/2019)... ... October 23, 2019 , ... ... Pico Automated Cell Imaging System including Digital Confocal 2D on-the-fly deconvolution, Live ... option allows scientists to decrease exposure time and improve the statistical significance ...
(Date:10/26/2019)... SOMERSET, N.J. (PRWEB) , ... ... ... leading global provider of advanced delivery technologies, development, and manufacturing solutions for ... give two presentations during the “Manufacturing and Bioprocessing Track” at the forthcoming ...
(Date:10/22/2019)... ... 21, 2019 , ... Veran Medical continues its mission to help physicians diagnose ... These devices are designed to help diagnose and guide treatment of small suspicious nodules, ... at the annual American College of Chest Physicians (CHEST) annual meeting in New Orleans, ...
Breaking Biology News(10 mins):
(Date:11/2/2019)... TORONTO (PRWEB) , ... October 31, 2019 , ... ... are not always used to communicating with each other: study managers, principal investigators, ... cause misunderstandings if a party is not informed of the latest data, potentially ...
(Date:10/29/2019)... Conn. (PRWEB) , ... October 28, 2019 , ... ... Advisory Board: , , Professor Jack R Wands, MD, of ... and Wyeth (Pfizer) , Professor Gil Mor, MD, PhD, of Wayne State ...
(Date:10/22/2019)... ... 2019 , ... Catalent, a global leader in clinical supply services, today announced ... participate in a panel session titled “Cell and Gene Therapy Logistics” at the upcoming ... Chicago, on Oct. 28-30, 2019. , The panel session, on Wednesday, Oct. 30 at ...
(Date:10/15/2019)... ... ... award-winning tech PR agency at the epicenter of the future of PR, today announced that ... the Ragan’s Health Care PR & Marketing Awards. This award marks the second consecutive year ... its healthIT practice group grew by 18 percent in Q3 this year, driven by client ...
Breaking Biology Technology:
Cached News: